BioSpace News Archive

Business

TARGET PharmaSolutions to Advance NASH Research Through New Collaboration

TARGET Pharmasolutions, a real-world data solutions company, is pleased to announce that Novartis has entered into a long-term strategic alliance for TARGET-NASH.

January 10, 2018
·
2 min read
Pharm Country

Svelte Medical Systems Announces First Patient Enrolled in Pivotal OPTIMIZE Study

The Svelte IDS and RX systems utilize low profile, highly conformable stents and a new class of bioresorbable drug carrier eluting sirolimus.

January 10, 2018
·
4 min read
Biotech Bay

Kenneth Rainin Foundation Announces Grant Opportunity for IBD-Related Scientific Research

The Kenneth Rainin Foundation will accept Letters of Inquiry online for its Innovator Awards program from January 15 through February 15, 2018.

January 10, 2018
·
3 min read
BioCapital

AstraZeneca’s BYDUREON BCise Injectable Medicine Now Available in the U.S. for Patients With Type-2 Diabetes

BYDUREON BCise is a new formulation of BYDUREON injectable suspension 2mg in an improved once-weekly, single-dose autoinjector device.

January 10, 2018
·
8 min read
Business

Propanc Biopharma Engages Alan Morell of Creative Management Partners as Senior Strategic Advisor to CEO and Board of Directors

Propanc Biopharma today announced the engagement of Mr. Alan Morell as a Senior Strategic Advisor for the Company, focusing on branding, growth strategy and market positioning.

January 10, 2018
·
5 min read
Biotech Beach

Cercacor’s Ember Now Monitors Carbon Monoxide and Methemoglobin in the Blood, Non-Invasively

Cercacor today announced that users can now also measure and monitor the dyshemoglobins carboxyhemoglobin and methemoglobin.

January 10, 2018
·
4 min read
Biotech Bay

Verseon Presents Hereditary Angioedema Program at 2018 Biotech Showcase Conference

Verseon presented preclinical results in its hereditary angioedema program at the 2018 Biotech Showcase in San Francisco yesterday, January 9.

January 10, 2018
·
2 min read
Business

Sosei Subsidiary, Heptares, Enters Drug R&D Collaboration With Imperial College London Focused on Multiple GPCR Disease Target Opportunities in the Gastro-Intestinal Tract

The strategic multi-year collaboration brings together complementary teams at Heptares and Imperial College London seeking to rapidly advance drug discovery and translational research focused on multiple new and existing GPCR disease target opportunities associated with the GI tract.

January 10, 2018
·
2 min read
Bio NC

Syneos Health Releases 2018 Commercial Trends Forecast

The company is the the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO.

January 10, 2018
·
6 min read
Business

Easton Pharmaceuticals Announces the Appointment of Mr. Luigi Gentile as Director and Officer to the Company

Luigi brings to Easton Pharmaceuticals a broad history of commercial leadership and innovation experience leading sales, marketing, product management and R&D teams in Healthcare

January 10, 2018
·
4 min read